Literature DB >> 7983654

Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses.

L R Espinoza1, J L Aguilar, C G Espinoza, M L Cuéllar, E Scopelitis, L H Silveira.   

Abstract

OBJECTIVE: To explore the potential role of fibroblasts in the pathogenesis of psoriasis and its related arthritis. Specifically, we analyzed the cell cycle of psoriatic fibroblasts obtained from skin and synovium by flow cytometry, and we also studied their response to several growth factors.
METHODS: Fibroblast cultures were established from normal and psoriatic skin, uninvolved and involved, and synovium. NIH-3T3 cells were also used as indicator cells in some of the experiments. Fibroblasts DNA cell cycle analysis was performed by flow cytometry, and the data was analyzed by using the "Cytologic DNA applications software version 2." In addition, fibroblasts were stimulated with growth factors including epidermal growth factor, transforming growth factor-beta, and platelet derived growth factor.
RESULTS: A significant increase of S and G2-M phase values in confluent cultures of psoriatic fibroblasts in both skin and synovium compared to normal fibroblasts was found. Psoriatic fibroblasts also exhibited a greater proliferative response to growth factors compared to normal fibroblasts.
CONCLUSION: Data obtained clearly showed a significant intrinsic in vitro alteration in skin and synovium fibroblasts from patients with psoriasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983654

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  [Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

Review 2.  The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2018-08-09       Impact factor: 4.592

Review 3.  Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.

Authors:  Dafna D Gladman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis.

Authors:  Shinji Maeda; Yoshihito Hayami; Taio Naniwa; Ryuzo Ueda
Journal:  Int J Rheumatol       Date:  2012-04-01

5.  Infliximab (Remicade) in the treatment of psoriatic arthritis.

Authors:  Philip Mease
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

Review 6.  Bone-immune cell crosstalk: bone diseases.

Authors:  Giorgio Mori; Patrizia D'Amelio; Roberta Faccio; Giacomina Brunetti
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.